Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableNot Yet RecruitingNCT07704294
What this trial is testing

Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool

Who this might be right for
Optic NeuritisMultiple SclerosisNeuromyelitis Optica Spectrum Disorder+2 more
King's College London 180
Not applicableLooking for participantsNCT06617962
What this trial is testing

Evaluation of Two Cell-based Assays for Diagnosing MOG-IgG Associated Disorders

Who this might be right for
Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders
Huashan Hospital 240
Not applicableEnrolling By InvitationNCT07636876
What this trial is testing

The Italian Multiple Sclerosis and Related Disorders Register

Who this might be right for
Multiple SclerosisNeuromyelitis OpticaDemyelinating Diseases of the Central Nervous System+3 more
Fondazione Italiana Sclerosi Multipla 96,000
Not applicableLooking for participantsNCT03900221
What this trial is testing

French Registry for Monitoring Pregnancies for Multiple Sclerosis

Who this might be right for
Sclerosis, MultipleNeuromyelitis Optica Spectrum DisorderMyelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders+1 more
Hospices Civils de Lyon 1,500
Not applicableLooking for participantsNCT05204459
What this trial is testing

MS-ResearchBiomarkerS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+8 more
Cedars-Sinai Medical Center 1,000